27
Participants
Start Date
August 4, 2020
Primary Completion Date
June 2, 2021
Study Completion Date
January 10, 2022
Melphalan
Peripheral versus central administration
Dexamethasone
Oral tablets
University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology, Brno
University Hospital Olomouc, Clinic of Hemato-Oncology, Olomouc
The Oncology Institute of Hope & Innovation - Glendale, Glendale
Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Sofia
"Multiprofile Hospital for Active Treatment Sveta Marina, Varna", Varna
Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Department of Hematology and Stem Cell Transplantation, Budapest
Semmelweis University, 3rd Department of Internal Medicine, Budapest
"Public Non-Profit Enterprise City Clinical Hospital #4 under Dnipro City Council, Regional Hematology Center", Dnipro
"Public Non-Profit Enterprise Kyiv City Clinical Hospital #9 under the Executive Body of Kyiv City Council, Hematology Department #1", Kyiv
Institute of Blood Pathology and Transfusion Medicine, Department of Hematology with Laboratory Group, Lviv
Lead Sponsor
Oncopeptides AB
INDUSTRY